217 related articles for article (PubMed ID: 10414351)
1. Structure and functions of inhibitory and excitatory glycine receptors.
Betz H; Kuhse J; Schmieden V; Laube B; Kirsch J; Harvey RJ
Ann N Y Acad Sci; 1999 Apr; 868():667-76. PubMed ID: 10414351
[TBL] [Abstract][Full Text] [Related]
2. Mutations within the agonist-binding site convert the homomeric alpha1 glycine receptor into a Zn2+-activated chloride channel.
Grudzinska J; Schumann T; Schemm R; Betz H; Laube B
Channels (Austin); 2008; 2(1):13-8. PubMed ID: 18690053
[TBL] [Abstract][Full Text] [Related]
3. The human glycine receptor beta subunit: primary structure, functional characterisation and chromosomal localisation of the human and murine genes.
Handford CA; Lynch JW; Baker E; Webb GC; Ford JH; Sutherland GR; Schofield PR
Brain Res Mol Brain Res; 1996 Jan; 35(1-2):211-9. PubMed ID: 8717357
[TBL] [Abstract][Full Text] [Related]
4. Disruption of a Structurally Important Extracellular Element in the Glycine Receptor Leads to Decreased Synaptic Integration and Signaling Resulting in Severe Startle Disease.
Schaefer N; Berger A; van Brederode J; Zheng F; Zhang Y; Leacock S; Littau L; Jablonka S; Malhotra S; Topf M; Winter F; Davydova D; Lynch JW; Paige CJ; Alzheimer C; Harvey RJ; Villmann C
J Neurosci; 2017 Aug; 37(33):7948-7961. PubMed ID: 28724750
[TBL] [Abstract][Full Text] [Related]
5. Identification of an inhibitory Zn2+ binding site on the human glycine receptor alpha1 subunit.
Harvey RJ; Thomas P; James CH; Wilderspin A; Smart TG
J Physiol; 1999 Oct; 520 Pt 1(Pt 1):53-64. PubMed ID: 10517800
[TBL] [Abstract][Full Text] [Related]
6. Glycine receptor knock-in mice and hyperekplexia-like phenotypes: comparisons with the null mutant.
Findlay GS; Phelan R; Roberts MT; Homanics GE; Bergeson SE; Lopreato GF; Mihic SJ; Blednov YA; Harris RA
J Neurosci; 2003 Sep; 23(22):8051-9. PubMed ID: 12954867
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for zinc potentiation at strychnine-sensitive glycine receptors.
Miller PS; Da Silva HM; Smart TG
J Biol Chem; 2005 Nov; 280(45):37877-84. PubMed ID: 16144831
[TBL] [Abstract][Full Text] [Related]
8. Agonist pharmacology of neonatal and adult glycine receptor alpha subunits: identification of amino acid residues involved in taurine activation.
Schmieden V; Kuhse J; Betz H
EMBO J; 1992 Jun; 11(6):2025-32. PubMed ID: 1376243
[TBL] [Abstract][Full Text] [Related]
9. Zinc potentiation of the glycine receptor chloride channel is mediated by allosteric pathways.
Lynch JW; Jacques P; Pierce KD; Schofield PR
J Neurochem; 1998 Nov; 71(5):2159-68. PubMed ID: 9798943
[TBL] [Abstract][Full Text] [Related]
10. Mutation of a zinc-binding residue in the glycine receptor α1 subunit changes ethanol sensitivity in vitro and alcohol consumption in vivo.
McCracken LM; Blednov YA; Trudell JR; Benavidez JM; Betz H; Harris RA
J Pharmacol Exp Ther; 2013 Feb; 344(2):489-500. PubMed ID: 23230213
[TBL] [Abstract][Full Text] [Related]
11. Chloride channels of glycine and GABA receptors with blockers: Monte Carlo minimization and structure-activity relationships.
Zhorov BS; Bregestovski PD
Biophys J; 2000 Apr; 78(4):1786-803. PubMed ID: 10733960
[TBL] [Abstract][Full Text] [Related]
12. Glycine-gated chloride channels depress synaptic transmission in rat hippocampus.
Song W; Chattipakorn SC; McMahon LL
J Neurophysiol; 2006 Apr; 95(4):2366-79. PubMed ID: 16381810
[TBL] [Abstract][Full Text] [Related]
13. Transient Receptor Potential Vanilloid 4 Activation-Induced Increase in Glycine-Activated Current in Mouse Hippocampal Pyramidal Neurons.
Qi M; Wu C; Wang Z; Zhou L; Men C; Du Y; Huang S; Chen L; Chen L
Cell Physiol Biochem; 2018; 45(3):1084-1096. PubMed ID: 29439248
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of the receptor-associated protein gephyrin changes the ligand binding affinities of alpha 2 glycine receptors.
Takagi T; Pribilla I; Kirsch J; Betz H
FEBS Lett; 1992 Jun; 303(2-3):178-80. PubMed ID: 1318846
[TBL] [Abstract][Full Text] [Related]
15. Molecular pharmacology of the glycine receptor chloride channel.
Webb TI; Lynch JW
Curr Pharm Des; 2007; 13(23):2350-67. PubMed ID: 17692006
[TBL] [Abstract][Full Text] [Related]
16. The startle disease mutation Q266H, in the second transmembrane domain of the human glycine receptor, impairs channel gating.
Moorhouse AJ; Jacques P; Barry PH; Schofield PR
Mol Pharmacol; 1999 Feb; 55(2):386-95. PubMed ID: 9927632
[TBL] [Abstract][Full Text] [Related]
17. The Startle Disease Mutation E103K Impairs Activation of Human Homomeric α1 Glycine Receptors by Disrupting an Intersubunit Salt Bridge across the Agonist Binding Site.
Safar F; Hurdiss E; Erotocritou M; Greiner T; Lape R; Irvine MW; Fang G; Jane D; Yu R; Dämgen MA; Biggin PC; Sivilotti LG
J Biol Chem; 2017 Mar; 292(12):5031-5042. PubMed ID: 28174298
[TBL] [Abstract][Full Text] [Related]
18. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
Vandenberg RJ; Rajendra S; French CR; Barry PH; Schofield PR
Mol Pharmacol; 1993 Jul; 44(1):198-203. PubMed ID: 8393521
[TBL] [Abstract][Full Text] [Related]
19. Glycine-receptor activation is required for receptor clustering in spinal neurons.
Kirsch J; Betz H
Nature; 1998 Apr; 392(6677):717-20. PubMed ID: 9565032
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory glycine receptors: an update.
Dutertre S; Becker CM; Betz H
J Biol Chem; 2012 Nov; 287(48):40216-23. PubMed ID: 23038260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
